Obesity reduces the pro-angiogenic potential of adipose tissue stem cell-derived extracellular vesicles (EVs) by impairing miR-126 content: Impact on clinical applications

International Journal of Obesity

Volumn 40, Issue 1, 2016, Pages 102-111

  Togliatto, G ^a   Dentelli, P ^a   Gili, M ^a   Gallo, S ^a   Deregibus, C ^a   Biglieri, E ^a   Iavello, A ^a   Santini, E ^b   Rossi, C ^b   Solini, A ^b   Camussi, G ^a   Brizzi, M F ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; GELATINASE A; GLUCOSE; MICRORNA 126; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PALMITIC ACID; PROTEIN; SPRED1 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; MICRORNA; MIRN126 MICRORNA, HUMAN; VASCULOTROPIN A;

ABDOMINAL SURGERY; ADIPOSE DERIVED STEM CELL; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; EXOSOME; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRAABDOMINAL FAT; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; ULTRACENTRIFUGATION; UPREGULATION; WESTERN BLOTTING; ADIPOGENESIS; ADULT STEM CELL; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECTS; METABOLISM; MICROVASCULATURE; PATHOLOGY; PATHOPHYSIOLOGY;

ADIPOGENESIS; ADULT STEM CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; ENDOTHELIAL CELLS; EXTRACELLULAR VESICLES; HUMANS; INTRA-ABDOMINAL FAT; MICRORNAS; MICROVESSELS; OBESITY; SUBCUTANEOUS FAT; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84953359560     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2015.123     Document Type: Article

References (48)

1. Imes CC, Burke LE. The obesity epidemic: the United States as a cautionary tale for the rest of the world. Curr Epidemiol Rep 2014; 1: 82-88.
2. Lepor NE, Fouchia DD, McCullough PA. New vistas for the treatment of obesity: turning the tide against the leading cause of morbidity and cardiovascular mortality in the developed world. Rev Cardiovasc Med 2013; 14: 20-39.
3. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13: 4279-4295.
4. Gimble JM, Katz AJ, Bunnell BA. Adipose derived stem cells for regenerative medicine. Circ Res 2007; 100: 1249-1260.
5. Schaffler A, Buchler C. Concise review: adipose tissue-derived stromal cells-basic and clinical implications for novel cell-based therapies. Stem Cells 2007; 25: 818-827.
6. Dentelli P, Barale C, Togliatto G, Trombetta A, Olgasi C, Gili M et al. A diabetic milieu promotes OCT4 and NANOG production in human visceral-derived adipose stem cells. Diabetologia 2013; 56: 173-184.
7. Kokai LE, Marra K, Rubin JP. Adipose stem cells: biology and clinical applications for tissue repair and regeneration. Transl Res 2014; 163: 399-408.
8. Kono TM, Sims EK, Moss DR, Yamamoto W, Ahn G, Diamond J et al. Human adipose-derived stromal/stem cells protect against STZ-induced hyperglycemia: analysis of hASC-derived paracrine effectors. Stem Cells 2014; 32: 1831-1842.
9. Ratajczak J, Kucia M, Mierzejewska K, Marlicz W, Pietrzkowski Z, Wojakowski W et al. Paracrine proangiopoietic effects of human umbilical cord blood-derived purified CD133+ cells-implications for stem cell therapies in regenerative medicine. Stem Cells Dev 2013; 22: 422-430.
10. Ratajczak MZ. A novel view of the adult bone marrow stem cell hierarchy and stem cell trafficking. Leukemia 2014; 29: 776-782.
11. Quesenberry PJ, Goldberg LR, Aliotta JM, Dooner MS, Pereira MG, Wen S et al. Cellular phenotype and extracellular vesicles: basic and clinical considerations. Stem Cells Dev 2014; 23: 1429-1436.
12. De Jong OG, Van Balkom BW, Schiffelers RM, Bouten CV, Verhaar MC. Extracellular vesicles: potential roles in regenerative medicine. Front Immunol 2014; 5: 608.
13. Record M, Subra C, Silvente-Poirot S, Poirot M. Exosomes as intercellular signalosomes and pharmacological effectors. Biochem Pharmacol 2011; 81: 1171-1182.
14. Tetta C, Ghigo E, Silengo L, Deregibus MC, Camussi G. Extracellular vesicles as an emerging mechanism of cell-to-cell communication. Endocrine 2013; 44: 11-19.
15. Eirin A, Riester SM, Zhu XY, Tang H, Evans JM, O'Brien D et al. MicroRNA and mRNA cargo of extracellular vesicles from porcine adipose tissue-derived mesenchymal stem cells. Gene 2014; 551: 55-64.
16. Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 2010; 107: 1047-1057.
17. Ranghino A, Cantaluppi V, Grange C, Vitillo L, Fop F, Biancone L et al. Endothelial progenitor cell-derived microvesicles improve neovascularization in a murine model of hindlimb ischemia. Int J Immunopathol Pharmacol 2012; 25: 75-85.
18. Cantaluppi V, Gatti S, Medica D, Figliolini F, Bruno S, Deregibus MC et al. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int 2012; 82: 412-427.
19. Bruno S, Grange C, Collino F, Deregibus MC, Cantaluppi V, Biancone L et al. Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS One 2012; 7: e33115.
20. Herrera MB, Fonsato V, Bruno S, Grange C, Gilbo N, Romagnoli R et al. Human liver stem cells improve liver injury in a model of fulminant liver failure. Hepatology 2013; 57: 311-319.
21. Bruno S, Collino F, Tetta C, Camussi G. Dissecting paracrine effectors for mesenchymal stem cells. Adv Biochem Eng Biotechnol 2013; 129: 137-152.
22. Colombo M, Raposo G, Théry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 2014; 30: 255-289.
23. Loyer X, Vion AC, Tedgui A, Boulanger CM. Microvesicles as cell-cell messengers in cardiovascular diseases. Circ Res 2014; 114: 345-353.
24. Wang Y, Chen LM, Liu ML. Microvesicles and diabetic complications-novel mediators, potential biomarkers and therapeutic targets. Acta Pharmacol Sin 2014; 35: 433-443.
25. Trombetta A, Togliatto G, Rosso A, Dentelli P, Olgasi C, Cotogni P et al. Increase of palmitic acid concentration impairs endothelial progenitor cell and bone marrowderived progenitor cell bioavailability: role of the STAT5/PPAR transcriptional complex. Diabetes 2013; 62: 1245-1257.
26. Togliatto G, Trombetta A, Dentelli P, Rosso A, Brizzi MF. MIR221/MIR222-driven post-transcriptional regulation of P27KIP1 and P57KIP2 is crucial for high-glucoseand AGE-mediated vascular cell damage. Diabetologia 2011; 54: 1930-1940.
27. Deregibus MC, Cantaluppi V, Calogero R, Lo Iacono M, Tetta C, Biancone L et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 2007; 110: 2440-2448.
28. Lopatina T, Bruno S, Tetta C, Kalinina N, Porta M, Camussi G. Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential. Cell Commun Signal 2014; 12: 26.
29. Fonsato V, Collino F, Herrera MB, Cavallari C, Deregibus MC, Cisterna B et al. Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs. Stem Cells 2012; 30: 1985-1998.
30. Olgasi C, Dentelli P, Rosso A, Iavello A, Togliatto G, Toto V et al. DNA vaccination against membrane-bound Kit ligand: a new approach to inhibiting tumour growth and angiogenesis. Eur J Cancer 2014; 50: 234-246.
31. Togliatto G, Trombetta A, Dentelli P, Gallo S, Rosso A, Cotogni P et al. Unacylated ghrelin (UnAG) induces oxidative stress resistance in a glucose intolerance mouse model and peripheral artery disease by restoring endothelial cell miR-126 expression. Diabetes 2015; 64: 1370-1382.
32. Baglioni S, Francalanci M, Squecco R, Lombardi A, Cantini G, Angeli R et al. Characterization of human adult stem-cell populations isolated from visceral and subcutaneous adipose tissue. FASEB J 2009; 23: 3494-3505.
33. Schreml S, Babilas P, Fruth S, Orsó E, Schmitz G, Mueller MB et al. Harvesting human adipose tissue-derived adult stem cells: resection versus liposuction. Cytotherapy 2009; 11: 947-957.
34. Dignat-George F, Boulanger CM. The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol 2011; 31: 27-33.
35. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA et al. The endothelialspecific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 2008; 15: 261-271.
36. Rauschert S, Uhl O, Koletzko B, Hellmuth C. Metabolomic biomarkers for obesity in humans: a short review. Ann Nutr Metab 2014; 64: 314-324.
37. György B, Szabó TG, Pásztoí M, Pál Z, Misják P, Aradi B et al. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 2011; 68: 2667-2688.
38. Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 2010; 12: 19-30.
39. Gangoda L, Boukouris S, Liem M, Kalra H, Mathivanan S. Extracellular vesicles including exosomes are mediators of signal transduction: Are they protective or pathogenic Proteomics 2014; 15: 260-271.
40. Hsiao YH, Lin CI, Liao H, Chen YH, Lin SH. Palmitic acid-induced neuron cell cycle G2/M arrest and endoplasmic reticular stress through protein palmitoylation in SH-SY5Y human neuroblastoma cells. Int J Mol Sci 2014; 15: 20876-20899.
41. Colombo M, Raposo G, Théry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 2014; 30: 255-289.
42. Kucharzewska P, Belting M. Emerging roles of extracellular vesicles in the adaptive response of tumour cells to microenvironmental stress. J Extracell Vesicles 2013; 2: doi:10.3402/jev.v2i0.20304.
43. Al-Goblan AS, Al-Alfi MA, Khan MZ. Mechanism linking diabetes mellitus and obesity. Diabetes Metab Syndr Obes 2014; 7: 587-591.
44. Mocharla P, Briand S, Giannotti G, Dörries C, Jakob P, Paneni F et al. AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics. Blood 2013; 121: 226-236.
45. Jansen F, Yang X, Hoelscher M, Cattelan A, Schmitz T, Proebsting S et al. Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles. Circulation 2013; 128: 2026-2038.
46. Simerman AA, Dumesic DA, Chazenbalk GD. Pluripotent muse cells derived from human adipose tissue: a new perspective on regenerative medicine and cell therapy. Clin Transl Med 2014; 3: 12.
47. Katsuda T, Kosaka N, Takeshita F, Ochiya T. The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Proteomics 2013; 13: 1637-1653.
48. Lindoso RS, Collino F, Bruno S, Araujo DS, Sant'Anna JF, Tetta C et al. Extracellular vesicles released from mesenchymal stromal cells modulate miRNA in renal tubular cells and inhibit ATP depletion injury. Stem Cells Dev 2014; 23: 1809-1819.